Follow
Cevriye Pamukcu
Cevriye Pamukcu
Immunocore
Verified email at immunocore.com
Title
Cited by
Cited by
Year
Boosting natural killer cell-mediated targeting of sarcoma through DNAM-1 and NKG2D
EC Sayitoglu, AM Georgoudaki, M Chrobok, D Ozkazanc, BJ Josey, M Arif, ...
Frontiers in immunology 11, 40, 2020
482020
Engineering antigen‐specific NK cell lines against the melanoma‐associated antigen tyrosinase via TCR gene transfer
A Parlar, EC Sayitoglu, D Ozkazanc, AM Georgoudaki, C Pamukcu, ...
European journal of immunology 49 (8), 1278-1290, 2019
382019
Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination
FB Oktelik, V Yilmaz, MY Gelmez, N Akdeniz, C Pamukcu, T Sutlu, M Kose, ...
Canadian Journal of Microbiology 68 (8), 543-550, 2022
32022
Lentiviral vector-based SARS-CoV-2 pseudovirus enables analysis of neutralizing activity in COVID-19 convalescent plasma
C Pamukcu, E Celik, EZ Ergun, ZS Karahan, G Turkoz, M Aras, C Eren, ...
BioRxiv, 2020.12. 28.424590, 2020
22020
A colorimetric pseudovirus-based assay using secreted embryonic alkaline phosphatase for analysis of neutralizing activity against SARS-CoV-2
C Pamukcu, M Aras, E Celik, EZ Ergun, ZS Karahan, T Sutlu
European Journal of Immunology, 112-112, 2021
2021
Development of a pseudovirus-based assay for analysis of neutralizing activity against SARS-CoV-2 in convalescent plasma
M Aras, C Pamukcu, E Celik, EZ Ergun, ZS Karahan, G Turkoz, C Eren, ...
European Journal of Immunology, 368-368, 2021
2021
Development of a pseudovirus-based assay for analysis of neutralizing activity against SARS-CoV-2
C Pamukcu
2021
Engineering antigen-specific natural killer cells against the melanoma-associated antigen tyrosinase via TCR gene transfer.
A Parlar, EC Sayitoglu, C Pamukcu, AM Georgoudaki, D Ozkazanc, ...
CANCER IMMUNOLOGY RESEARCH 8 (4), 49-50, 2020
2020
Abstract A21: Engineering antigen-specific natural killer cells against the melanoma-associated antigen tyrosinase via TCR gene transfer
A Parlar, EC Sayitoglu, C Pamukcu, AM Georgoudaki, D Ozkazanc, ...
Cancer Immunology Research 8 (4_Supplement), A21-A21, 2020
2020
Engineering antigen-specific NK cells via TCR gene transfer: a novel source for adoptive immunotherapy
A Parlar, C Pamukcu, D Özkazanç, M Aras, C Dahlberg, M Chrobok, ...
Mary Ann Liebert 28 (12), A31-A32, 2017
2017
Effect of mesenchymal cell delivered TRAIL and/or Dkk-1 on cancer cell viability
F Sahin, C Pamukcu, E Yalvac
FEBS JOURNAL 280, 453-453, 2013
2013
Crosstalk Between Human Tooth Germ Derived Mesenchymal Stem Cells and Cancer Cells
C Pamukcu, ME Yalvaç, A Rizvanov, F Şahin
HUMAN GENE THERAPY 22 (10), A55-A56, 2011
2011
The system can't perform the operation now. Try again later.
Articles 1–12